scispace - formally typeset
K

Keith L. Shelton

Researcher at Virginia Commonwealth University

Publications -  42
Citations -  1319

Keith L. Shelton is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Stimulus control & GABAA receptor. The author has an hindex of 19, co-authored 38 publications receiving 1216 citations.

Papers
More filters
Journal ArticleDOI

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

TL;DR: Depression and stress are two states during cocaine abstinence which users identify as precipitating relapse, and JDTic may have properties which attenuate both.
Journal ArticleDOI

Rat Nucleus Accumbens Core Astrocytes Modulate Reward and the Motivation to Self-Administer Ethanol after Abstinence

TL;DR: It is found that the packing density of astrocytes that were expressing glial fibrillary acidic protein increased in the nucleus accumbens core (NAcore) during abstinence from EtOH self-administration, demonstrating that NAcore astroCytes can shape the motivation to self-administer ethanol.
Journal ArticleDOI

Genomic analysis of individual differences in ethanol drinking: evidence for non-genetic factors in C57BL/6 mice.

TL;DR: It is found that a histone deacetylase inhibitor, trichostatin A, caused an increase in 2-bottle ethanol intake, which implicate specific brain regional gene networks as potentially important mechanisms underlying individual variation in ethanol intake.
Journal ArticleDOI

Characterization of the ethanol-deprivation effect in substrains of C57BL/6 mice

TL;DR: A simple and reliable behavioral model to study EDE in inbred C57BL/6NCrl mice is established and could greatly facilitate further studies on molecular mechanisms of ethanol craving behavior.
Journal ArticleDOI

The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.

TL;DR: AV411 has properties consistent with the ability to attenuate relapse precipitated by stress and methamphetamine "slips" during abstinence, and reinforces interest in atypical neurobiological mechanisms which could be exploited for developing novel medications for treating drug abuse disorders.